Afatinib for the treatment of patients with EGFR-positive non-small cell lung cancer.
Bowles DW, Weickhardt A, Jimeno A. Afatinib for the treatment of patients with EGFR-positive non-small cell lung cancer. Drugs Today (Barc). 2013 Sep; 49(9):523-35.